Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Haematologica|October 15, 2020
Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapiesIvan Arias De la Rosa, Carlos Perez-Sanchez, Patricia Ruiz-Limon, et al.
Pediatric Rheumatology Online Journal|July 16, 2020
Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remissionInmaculada Concepción Aranda-Valera, Iván Arias de la Rosa, Rosa Roldán-Molina, et al.
Frontiers in Endocrinology|March 7, 2024
Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluationIgnacio Gómez-García, Maria L Ladehesa-Pineda, Juan M Diaz-Tocados, et al.
Rheumatology International|September 16, 2019
LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patientsIvan Castellví, Saioa Eguiluz, Alejandro Escudero-Contreras, et al.
Journal of Biomedical Science|April 19, 2020
Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectivenessPatricia Ruiz-Limon, Maria Lourdes Ladehesa-Pineda, Maria Del Carmen Castro-Villegas, et al.
Frontiers in Immunology|June 7, 2019
Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid ArthritisPatricia Ruiz-Limon, Rafaela Ortega-Castro, Nuria Barbarroja, et al.
RMD Open|January 27, 2026
Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progressionLaura Cuesta-López, Iván Arias-de la Rosa, Carlos Pérez-Sánchez, et al.
Reumatologia Clinica|November 26, 2022
Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world settingSara Marsal Barril, Mª Auxiliadora Martin-Martinez, Francisco Javier Blanco-Garcia, et al.
Therapeutic Advances in Chronic Disease|April 2, 2021
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritisIván Arias de la Rosa, Pilar Font, Alejandro Escudero-Contreras, et al.
RMD Open|February 23, 2024
Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective studyClementina López-Medina, Jerusalem Calvo-Gutiérrez, M Carmen Ábalos-Aguilera, et al.
Pageof 8